These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 37559735)
41. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants. Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999 [TBL] [Abstract][Full Text] [Related]
42. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19? Scaggs Huang F J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545 [TBL] [Abstract][Full Text] [Related]
43. Longitudinal change in SARS-CoV-2 seroprevalence in 3-to 16-year-old children: The Augsburg Plus study. Leone V; Meisinger C; Temizel S; Kling E; Gerstlauer M; Frühwald MC; Burkhardt K PLoS One; 2022; 17(8):e0272874. PubMed ID: 35951611 [TBL] [Abstract][Full Text] [Related]
44. SARS-CoV-2 antibody persistence after five and twelve months: A cohort study from South-Eastern Norway. Sarjomaa M; Diep LM; Zhang C; Tveten Y; Reiso H; Thilesen C; Nordbø SA; Berg KK; Aaberge I; Pearce N; Kersten H; Vandenbroucke JP; Eikeland R; Fell AKM PLoS One; 2022; 17(8):e0264667. PubMed ID: 35947589 [TBL] [Abstract][Full Text] [Related]
45. Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes. Lin DY; Gu Y; Xu Y; Wheeler B; Young H; Sunny SK; Moore Z; Zeng D JAMA; 2022 Oct; 328(14):1415-1426. PubMed ID: 36155617 [TBL] [Abstract][Full Text] [Related]
46. Perinatal Complications in Individuals in California With or Without SARS-CoV-2 Infection During Pregnancy. Ferrara A; Hedderson MM; Zhu Y; Avalos LA; Kuzniewicz MW; Myers LC; Ngo AL; Gunderson EP; Ritchie JL; Quesenberry CP; Greenberg M JAMA Intern Med; 2022 May; 182(5):503-512. PubMed ID: 35311909 [TBL] [Abstract][Full Text] [Related]
47. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308 [TBL] [Abstract][Full Text] [Related]
48. Anti-Spike Antibody Response to Natural Infection with SARS-CoV-2 and Its Activity against Emerging Variants. Chen CP; Huang KA; Shih SR; Lin YC; Cheng CY; Huang YC; Lin TY; Cheng SH Microbiol Spectr; 2022 Aug; 10(4):e0074322. PubMed ID: 35703556 [TBL] [Abstract][Full Text] [Related]
49. Associations of habitual glucosamine use with SARS-CoV-2 infection and hospital admission and death with COVID-19: Evidence from a large population based cohort study. Meng M; Wu Y; Sha W; Zeng R; Luo D; Jiang R; Wu H; Zhuo Z; Yang Q; Li J; Leung FW; Duan C; Feng Y; Chen H J Med Virol; 2023 Apr; 95(4):e28720. PubMed ID: 37185863 [TBL] [Abstract][Full Text] [Related]
50. Immune Response of Neonates Born to Mothers Infected With SARS-CoV-2. Conti MG; Terreri S; Piano Mortari E; Albano C; Natale F; Boscarino G; Zacco G; Palomba P; Cascioli S; Corrente F; Capponi C; Mirabella M; Salinas AF; Marciano A; De Luca F; Pangallo I; Quaranta C; Alteri C; Russo C; Galoppi P; Brunelli R; Perno CF; Terrin G; Carsetti R JAMA Netw Open; 2021 Nov; 4(11):e2132563. PubMed ID: 34730817 [TBL] [Abstract][Full Text] [Related]
51. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study]. Özgür D; Tütüncü EE Mikrobiyol Bul; 2022 Jan; 56(1):36-48. PubMed ID: 35088958 [TBL] [Abstract][Full Text] [Related]
52. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity. McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155 [TBL] [Abstract][Full Text] [Related]
53. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial. Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302 [TBL] [Abstract][Full Text] [Related]
54. Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City. Dumitriu D; Emeruwa UN; Hanft E; Liao GV; Ludwig E; Walzer L; Arditi B; Saslaw M; Andrikopoulou M; Scripps T; Baptiste C; Khan A; Breslin N; Rubenstein D; Simpson LL; Kyle MH; Friedman AM; Hirsch DS; Miller RS; Fernández CR; Fuchs KM; Keown MK; Glassman ME; Stephens A; Gupta A; Sultan S; Sibblies C; Whittier S; Abreu W; Akita F; Penn A; D'Alton ME; Orange JS; Goffman D; Saiman L; Stockwell MS; Gyamfi-Bannerman C JAMA Pediatr; 2021 Feb; 175(2):157-167. PubMed ID: 33044493 [TBL] [Abstract][Full Text] [Related]
55. The Association between Noninfectious Uveitis and Coronavirus Disease 2019 Outcomes: An Analysis of United States Claims-Based Data. Miller DC; Sun Y; Chen EM; Arnold BF; Acharya NR Ophthalmology; 2022 Mar; 129(3):334-343. PubMed ID: 34648828 [TBL] [Abstract][Full Text] [Related]
56. Validation of the Diabetomics CovAB SARS-CoV-2 antibody test in children: comparison with serology. Gurumurthy M; Schwab J; Pentakota SR; Ukey R; Gennaro M; Thomas P; Friedman S Microbiol Spectr; 2024 Nov; 12(11):e0064624. PubMed ID: 39412297 [TBL] [Abstract][Full Text] [Related]
57. Nutritional deficiency anemia and post-acute sequelae in patients with severe acute respiratory syndrome coronavirus 2 infection: A six-month retrospective cohort analysis of 30 892 patients. Wu JY; Liu MY; Hung KC; Hsu WH; Tsai YW; Liu TH; Huang PY; Chuang MH; Hsieh YL; Lai CC; Kuo YH J Med Virol; 2023 Nov; 95(11):e29246. PubMed ID: 38010833 [TBL] [Abstract][Full Text] [Related]
58. Assessing the Burden and Cost of COVID-19 Across Variants in Commercially Insured Immunocompromised Populations in the United States: Updated Results and Trends from the Ongoing EPOCH-US Study. Ketkar A; Willey V; Glasser L; Dobie C; Wenziger C; Teng CC; Dube C; Hirpara S; Cunningham D; Verduzco-Gutierrez M Adv Ther; 2024 Mar; 41(3):1075-1102. PubMed ID: 38216825 [TBL] [Abstract][Full Text] [Related]
59. Real-world performance of SARS-Cov-2 serology tests in the United States, 2020. Rodriguez-Watson CV; Louder AM; Kabelac C; Frederick CM; Sheils NE; Eldridge EH; Lin ND; Pollock BD; Gatz JL; Grannis SJ; Vashisht R; Ghauri K; Knepper C; Leonard S; Embi PJ; Jenkinson G; Klesh R; Garner OB; Patel A; Dahm L; Barin A; Cooper DM; Andriola T; Byington CL; Crews BO; Butte AJ; Allen J PLoS One; 2023; 18(2):e0279956. PubMed ID: 36735683 [TBL] [Abstract][Full Text] [Related]
60. Anti-SARS-CoV-2 antibody levels predict outcome in COVID-19 patients with type 2 diabetes: a prospective cohort study. Mink S; Saely CH; Leiherer A; Frick M; Plattner T; Drexel H; Fraunberger P Sci Rep; 2023 Oct; 13(1):18326. PubMed ID: 37884649 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]